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Abstract: 
Echinacea purpurea (L.) Moench, a top selling botanical medicine, is currently of considerable 
interest due to immunomodulatory, anti-inflammatory, antiviral and cannabinoid receptor 2 
(CB2) binding activities of its alkylamide constituents. The purpose of these studies was to 
comprehensively profile the alkylamide (alkamide) content of E. purpurea root, and to compare 
yields of alkylamide constituents resulting from various ethanolic extraction procedures 
commonly employed by the dietary supplements industry. To accomplish this goal, a high 
performance liquid chromatography–electrospray ionization mass spectrometry (HPLC–ESI-
MS) method was validated for quantitative analysis of several E. purpurea alkylamides. Using 
this method, at least 15 alkylamides were identified and it was shown that fresh and dry E. 
purpurea extracts prepared from equivalent amounts (dry weight) of roots, with exceptions, 
exhibited similar yield of specific alkylamides. However, the amount of total dissolved solids in 
the dry extract was higher (by 38%) than the fresh extract. Two extracts prepared from dried 
roots at different ratios of root:solvent (1:5, w:v and 1:11, w:v) were similar in yield of total 
dissolved solids, but, there were differences in quantities of specific alkylamides extracted using 
these two root:solvent ratios. In addition, the important bioactive dodecatetraenoic acid 
isobutylamides are fully extracted from dry E. purpurea root in 2 days, suggesting that the 
manufacturing practice of macerating Echinacea extracts for weeks may be unnecessary for 
optimal alkylamide extraction. Finally, the identification of a new alkylamide has been proposed. 
These results demonstrate the differences of the described extractions and utility of the analytical 
methods used to determine the wide-ranging individual alkylamide content of commonly 
consumed Echinacea extracts. 
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1. Introduction 
The investigations described herein employ high performance liquid chromatography coupled to 
electrospray ionization mass spectrometry (HPLC–ESI-MS) for the comprehensive 
characterization of several extracts from the medicinal plant Echinacea purpurea (L.) Moench. 
Echinacea is widely used for the treatment of upper respiratory infections, and is a global top 
seller. Three main species of echinacea are used clinically and available to 
consumers, Echinacea pallida, E. purpurea and E. angustifolia. Of these, E. purpurearepresents 
80% of commercial production [1]. E. purpurea products range from the injectables prepared to 
rigorous European pharmaceutical manufacturing standards, to the low tech ethanolic extractions 
or “tinctures” that follow general manufacturing practices (GMPs) of the United States dietary 
supplements industry. Although in Germany the aerial parts are preferred, ethanolic extracts of 
echinacea root make up a large source of sales and clinical use in the United States. 
Manufacturing practices generally dictate whether the starting plant material should be fresh or 
dry, but in the case of echinacea species, both fresh and dry root extracts are commercially 
available. To further complicate matters, these extracts are prepared with varying ratios of 
plant:solvent depending on the manufacturer. Currently, there are few investigations comparing 
the efficiency of extracting active constituents under these various extraction conditions. The few 
studies investigating the extraction of alkylamides have generally utilized dried root, while 
alkylamide extraction of fresh roots has scarcely been studied [2]. There is currently a lack of 
information regarding differences in chemical composition among extracts prepared using fresh 
versus dried Echinacea. One of the goals of the studies conducted herein was to provide such 
information. 
Four constituent groups are currently believed to be the source of activity in the echinacea genus; 
alkylamides (alkamides), phenylpropanoids (caffeic acid derivatives), polysaccharides, and 
glycoproteins[3]. However, in extractions with ethanol concentrations above 40%, only very low 
levels of polysaccharides are left in suspension, and denaturing of proteins is expected [4] and [5]. 
Thus, the major constituents of ethanolic echinacea extracts are phenylpropanoids and 
alkylamides. To date, human pharmacokinetic studies of Echinacea spp. suggest that the 
alkylamides are the major constituent group circulated in plasma[6]. 
Alkylamides have been of pharmacological interest since the tingling paresthesia from chewing 
plants rich in these compounds were noted [7]. This anesthetic property was utilized by native 
Americans [8] and eventually by physicians in the early 20th century for a variety of purposes 
including as a sialogogue, antitussive and for toothache. Alkylamides were later recognized as 
insecticidal [9] and oncolytic [10]. Recent investigations have demonstrated immunomodulatory 
activity of alkylamides in vitro [11] and in vivo[12], as well as direct antiviral activity [13]. Most 
recently, these compounds have become a subject of interest due to their elucidation as agonists 
of the cannabinoid receptor 2 (CB2) receptor [14]. 
Given that the alkylamides appear to be one of the key constituent groups responsible for 
pharmacological activity of E. purpurea, the studies described herein focused on this class of 
constituents. A number of analytical studies, the bulk by Bauer et al., have relied on liquid 
chromatography with UV detection (LC-UV) to analyze echinacea alkylamides [15], [16], [17] and [18]. 
However, comprehensive profiling of echinacea alkylamide content using LC-UV alone has been 
challenging. These compounds are present at widely different concentrations, and many of them 
are isomeric. Consequently, co-elution of structurally similar alkylamides is common, and UV 
detectors may not detect minor alkylamide constituents because of low concentrations and/or co-
elution with other compounds. Mass spectrometry (MS) provides a distinct advantage over UV 
detectors due to its sensitivity and the ability to select by mass the ions corresponding to the 
compounds of interest [19]. As the data presented here will demonstrate, this advantage makes 
HPLC–ESI-MS an ideal technique for the comprehensive analysis of the isomeric alkylamide 
content in E. purpurea. Although several investigators have previously employed HPLC–ESI-
MS to the analysis of alkylamides in Echinacea [20], [21] and [22], none of the previous methods have 
been validated for quantitative purposes. Furthermore, because of the abundance of isomeric 
alkylamides in E. purpurea, even with the use of MS detectors, misidentification or incomplete 
identification of alkylamides has been common[22], [23] and [24]. With this study, we present the first 
validated HPLC–ESI-MS method for the analysis of alkylamides in E. purpurea. This method 
enables quantitative comparison of alkylamide content in various E. purpurea extracts. In 
addition, by relying on MS–MS fragmentation patterns to distinguish isomeric alkylamides, we 
report a more comprehensive profile of alkylamide content in E. purpurea than has previously 
been published. 
2. Experimental 
2.1. Reagents 
The following chemicals and reagents were used: 
Acetonitrile (high performance liquid chromatography (HPLC) grade) (Honeywell Burdick and 
Jackson, Muskegon, MI), acetic acid (Fisher Chemical, Fairlawn, NJ), alkylamide standards 
(Chromadex Inc., Santa Anna, CA), ethanol (AAPER, Shelbyville, KY), nanopure water 
(Nanopure Diamond D11931, Barnstead International, Thermolyne, Dubuque, IA). 
2.2. Plant material 
Cultivation of E. purpurea took place in Grants Pass, OR at Pacific Botanicals. Fresh, dormant 
roots of E. purpurea were harvested in March 2007. Species was verified by Richard Cech 
(Horizon Herbs, Williams, OR) and voucher specimens were submitted to the University of 
North Carolina Herbarium in Chapel Hill, NC (accession numbers 583416 and 583417). The 
roots were two years-old at time of harvest. 
2.3. Plant extractions 
A typical protocol [25] for the manufacture of ethanolic extracts was followed in all extractions, 
except that post washing, the roots were briefly soaked (5 min) in 70% ethanol as a disinfectant, 
and blown partially dry with compressed air. A loss of the isomeric dodeca-2,4,8,10-tetraenoic 
acid isobutylamides (tetraenes) of 1.4% (against final fresh root concentrations) was calculated 
from the initial rinse. The roots were then cut into small pieces (≤1 cm wide) and extracted using 
three different extraction techniques, fresh root extraction (1:2, w:v) and dry root extraction at 
two different root to solvent ratios, 1:11 and 1:5 (w:v). All ratios are expressed as mass raw plant 
material (E. purpurea roots) in weight (g) per volume (mL) of extraction solvent. 
To prepare fresh root extracts, samples of the cut roots (65 g) were blended using a Waring 
Blender (Tarrington, CT) in a solvent of 95% ethanol (AAPER, Shelbyville, KY) at a ratio of 1 g 
roots:2 mL solvent. Samples of root from the same batch were dried in an oven at 50 °C and 
water content was determined to be 74.5%. Dry root extractions were carried out with the same 
method as the fresh except that the solvent consisted of 74.5% ethanol and 25.5% water (to 
account for the plant water removed upon drying). To make these dry root extracts, 16.6 g of 
dried root was added to 179 mL of solvent (74.5% ethanol) for a ratio of 1:11 and 16.6 g of dried 
root was added to 83 mL of solvent (74.5% ethanol) for a ratio of 1:5. Four replicate extracts 
were prepared at each extraction ratio (fresh 1:2, dry 1:11 and dry 1:5). 
Aliquots (dry root 1:11, 200 μL) for the extraction as a function of time study were taken on a 
daily basis (days 2–33) during the process of maceration and stored at −70 °C until the time of 
analysis for alkylamide content. After maceration for one month, the solvent was removed from 
all of the extracts using a hydraulic press. The extracts were then aliquoted into 1 mL portions in 
polypropylene microcentrifuge tubes and kept in the dark at room temperature until needed for 
analysis. Previous investigations have established stability of alkylamides under these 
conditions [26]. All extractions were macerated at 24 °C. 
2.4. Preparation of samples and standards 
Prior to analysis, samples were removed from storage and allowed to reach room temperature. 
Aliquots (500 μL) from all extractions were centrifuged at 14,000 rpm (Savant Speedvac Sc110, 
Farmingdale, NY) for 5 min. Supernatant was then diluted in the same solvent used for 
extraction (70% ethanol), and pipetted (300 μL) into autosampler vials (Agilent Technologies, 
Santa Clara, CA) for LC-MS analysis. Several dilutions were prepared from each extract to 
adjust alkylamide content to within the linear dynamic range of the method. Neat samples were 
used for determination of dodeca-2E-ene-8,10-diynoic acid and1000-fold dilutions were used for 
analysis of the isomers of dodeda-2,4,8,10-tetraenoic acid isobutylamide. 
Alkylamide primary standards were purchased from Chromadex (Santa Anna, CA) with 
certificates of analysis verifying identity by NMR and HPLC, and purity of ≥99% by HPLC. 
Concentrated stock solutions of dodeca-2E-ene-8,10-diynoic acid isobutylamide (molecular 
weight 245.37, lot # 04950-601) and dodeca-2E,4E,8Z,10Z-tetraenoic acid isobutylamide 
(molecular weight 247.38, lot # 04953-102) were prepared at 5 mg/mL in ethanol and stored at 
4 °C. The stock solutions were diluted in ethanol to produce final concentrations of 0.1, 10, 50, 
100 and 500 μM. 
2.5. HPLC–ESI-MS analysis 
An ion trap mass spectrometer with electrospray ionization source (LCQ Advantage, 
ThermoFisher, San Jose, CA) was employed. The solvent gradient, which was a minor variation 
on that previously published[21], was as follows, where solvent A is aqueous acetic acid (17 mM, 
original pH 2.74) and solvent B is neat HPLC grade acetonitrile. For t = 0–4 min, a constant 
composition of A–B (90:10, v/v); for t = 4–15 min, a linear gradient from A–B (90:10, v/v) to 
A–B (60:40, v/v); for t = 15–30 min, a linear gradient from A–B (60:40, v/v) to A–B (40:60, 
v/v); for t = 30.1–35 min, a constant composition of A–B (0:100, v/v); for t = 35.1–43 min, a 
constant composition of A–B (90:10, v/v). The mass spectrometer was operated in the positive 
ion mode with a scan range of 50.00–2000.00. Spray, capillary, and tube lens offset voltages 
were 4.5 kV, 3 V and −60 V, respectively. 
2.6. Quantitative and qualitative analysis of alkylamides 
Constituents in the extracts were identified according to their molecular weights, HPLC retention 
times, and previously established MS–MS fragmentation patterns [27]. For quantitative 
determination of alkylamide content, calibration curves were plotted as the log of the area of the 
selected ion chromatogram for the protonated alkylamide of interest versus the log of 
concentration. Extract samples were analyzed neat and at 1000-fold dilution within the same run 
as the calibration standards. The concentrations of dodeca-2E-ene-8,10-diynoic acid 
isobutlyamide and of the isomers of dodeda-2,4,8,10-tetraenoic acid isobutylamide were 
determined by plugging the relevant peak area into the linear regression equation for the 
corresponding calibration curve. All samples for which quantitative comparisons were made 
were analyzed within a single run. 
2.7. Method validation 
Method validation was conducted according to International Committee of Harmonization (ICH) 
guideline[28]. Alkylamide standards prepared as described in Section 2.4 were analyzed in 
triplicate on three separate days (for a total of 9 analyses of each standard). To assess accuracy, a 
“measured concentration” for each standard was back-calculated from the corresponding 
calibration curve. The measured concentration reported was an average of the measured 
concentrations calculated on three separated days. This measured concentration was then 
compared to the theoretical concentration of each standard, and the % relative difference was 
reported as the “residual”. Repeatability was determined as the relative standard deviation among 
the back-calculated concentrations for the triplicate analyses of each standard within a single run. 
Intermediate precision was calculated as the relative standard deviation among the back-
calculated concentrations for three runs conducted on three separate days. The limit of detection 
(a measure of the sensitivity of the method) was determined based on the concentration required 
to give a signal to noise ratio (S:N) of 3:1 in the relevant selected ion chromatogram. Limit of 
quantitation was based on the signal necessary to achieve a S:N of 10:1. 
2.8. Statistical analysis 
The standard error of the mean (SEM) was determined for each set of concentrations or peak 
areas. Data are expressed as the mean ± SEM and comparison of means was conducted using a 
two tailed t-test for paired data when differences were observed. The mean values were 
considered significantly different if p < 0.05. Where appropriate, outlying data points were 
rejected on the basis of the Q-test. Statistical analyses were performed with Microsoft Excel 
(2003). 
2.9. Determination of yield of dissolved solids 
Polypropylene microcentrifuge tubes (1.5 mL) were weighed before addition of 500 μL aliquots 
of centrifuged extracts. After dehydration in the speedvac for 39 h at 24 °C, the mass of 
dissolved solids for each sample was determined. The ratio of the mass of dissolved solids to the 
amount of dry root used in the equivalent volume of extract was then calculated, providing a 
measure of the quantity of dissolved solids extracted per mass of Echinacea root (extract yield). 
For the fresh extract, the dry weight of the root used for the extract was calculated by subtracting 
the mass of the water contained in the roots from the total mass of the fresh roots. 
3. Results and discussion 
In this section, a comprehensive profile of alkylamide constituents in E. purpurea is listed, with a 
description of how these compounds can be identified using HPLC–ESI-MS. In addition, 
quantities of dissolved solids and specific alkylamides present in various E. purpurea extracts are 
compared. The extracts analyzed here were prepared using several different procedures 
commonly employed in the dietary supplement industry. Analysis of these extracts provides 
insight into the similarities and differences in extract composition that result from these 
variations in extraction technique. 
3.1. Identification of alkylamides 
Table 1 lists alkylamides identified from E. purpurea, with references that refer to publications 
in which these identifications were made. This is the most comprehensive listing of alkylamides 
of E. purpurea root to date. Most reports and reviews list some, but not all, of the alkylamides 
present in this species [16], [24],[29] and [30]. Past estimates suggest the presence of eleven alkylamides 
in the roots of E. purpurea [31] and [32]. Table 1, lists a total of 17 compounds, although, as 
described later on, some of these identifications are only tentative and one compound (C) was 
not detected in our samples of E. purpurea. 
Table 1. Alkylamides from Echinacea purpurea. 
Designation Alkylamide MW Reference 
A Undeca-2E,4Z-diene-8,10-diynoic acid isobutylamide 229.32 [32] 
B Undeca-2Z,4E-diene-8,10-diynoic acid isobutylamide 229.32 [42] 
C Undeca-2E-ene-8,10-diynoic acid isobutylamide 231.34 [35] 
D Undeca-2E,4Z-diene-8,10-diynoic acid 2-methylbutylamide 243.35 [32] 
E Undeca-2Z,4E-diene-8,10-diynoic acid 2-methylbutylamidea 243.35  
F Dodeca-2Z,4E-diene-8,10-diynoic acid isobutylamide 243.35 [42] 
G Dodeca-2E,4Z-diene-8,10-diynoic acid isobutylamide 243.35 [32] 
H Dodeca-2E,4E,10E-triene-8-ynoic acid isobutylamide 245.37 [32] 
J Dodeca-2E-ene-8,10-diynoic acid isobutylamideb 245.37 [35] 
K Dodeca-2E,4E,8Z,10E-tetraenoic acid isobutylamide 247.38 [32] 
L Dodeca-2E,4E, 8Z,10Z-tetraenoic acid isobutylamideb 247.38 [32] 
M Dodeca-2E,4E, 8E,10Z-tetraenoic acid isobutylamide 247.38 [38] 
N Dodeca-2E,4E,8Z-trienoic acid isobutylamide 249.40 [32] 
O Dodeca-2E,4E-dienoic acid isobutylamide 251 41 [31] 
P Trideca-2E,7Z-diene-8,10-diynoic acid isobutylamide 257.38 [31] 
Q Dodeca-2E,4Z-diene-8,10-diynoic acid 2-methylbutylamide 257.38 [40] 
R Dodeca-2,4,8,10-tetraenoic acid 2-methylbutylamide 261.41 [36] 
aProposed structure of newly identified alkylamide. bCompounds J and L were utilized as 
standards. 
Many of these compounds were present in the E. purpurea extracts investigated here, as 
demonstrated in Fig. 1. This figure shows a base peak chromatogram ( Fig. 1A) obtained from 
analysis of the 1:5 dry root E. purpurea extract. Peak labels correspond to alkylamide 
designations in Table 1, and were confirmed based on comparison of retention time with 
previous investigations [21] and MS–MS spectra ( Table 2, Fig. 2). A few of the minor 
alkylamides in the extract were obscured by co-elution with major alkylamides, but can be 
visualized through the use of selected ion chromatograms ( Fig. 1B–D). 
 
Fig. 1. Characteristic chromatograms obtained by liquid chromatography–mass spectrometry 
analysis of an E. purpurea root extract (1:5). Panel A shows a base peak chromatogram (plot of 
the most abundant ion in the mass spectrum versus time), with peak labels that correspond to the 
designations in Table 1. Several minor alkylamides that coelute with the compounds shown in 
the base peak chromatogram can be distinguished with selected ion chromatograms, as shown in 
panels B (mass range 245.5–246.5), C (mass range 249.5–250.5) and D (mass range 257.5–
258.5). 
Table 2. Fragments formed by collisionally induced dissociation (MS–MS) of the MH+ ion of 
various E. purpurea alkylamides. 
Designation, name, m/z Group id, 
RIc30–
90% 
Group iie, 
RI 30–
90% 
Group iiif, 
RI 60–
100% 
Group ivg, 
RI 26–
100% 
Group vh, 
RI < 3–
20% 
D 
244a 
Undeca-2E,4Z-diene-
8,10-diynoic acid 2-
metylbutyl amide 
157 129 131 174 188, 202, 
216 
E 
244 
Undeca-2Z,4E-diene-
8,10-diynoic acid 2-
methylbutylamideb 
157 129 131 174 188, 202, 
216 
F 
244 
Dodeca-2Z,4E-diene-
8,10-diynoic acid 
isobutylamide 
171 143 145 188 202, 216 
G 
244 
Dodeca-2E,4Z-diene-
8,10-diynoic acid 
isobutylamide 
171 143 145 188 202, 216 
P 
258 
Trideca-2Z,7E-diene-
8,10-diynoic acid 
isobutylamide 
185 157 159 202 216,230 
Q 
258 
Dodeca-2E,4Z-diene-
8,10-diynoic acid 2-
methylbutylamide 
171 143 145 188 202, 216 
a The number beneath the letter designation indicates the m/z value for the MH+ ion. b Proposed 
structure for compound E based on retention time and MS/MS fragmentation. c RI corresponds to 
relative intensity. d The group i fragments correspond to acyllium ions as shown in Fig. 2. e The 
group ii fragments are carbocations that correspond to the alkyl chain of the alkylamide and are 
formed by loss of the amide portion (isobutylamide or 2-methylbutylamide). f The 
group iii fragments correspond to the alkyl chain of the alkylamide and are formed by the loss of 
the amide portion of the molecule and saturation of one of the double bonds on the alkyl chain.   
g The group iv fragments correspond to the protonated alkylamide minus the N-alkyl group. h The 
group v fragments correspond to the protonated alkylamide minus various portions of the N-
alkyl group (see Fig. 2). 
  
Fig. 2. MS/MS spectra of isomeric alkylamides. This figure compares fragments that result from 
collisionally induced dissociation precursor ions that represent the protonated molecular ion 
(MH+) of a number of isomeric alkylamides. Even ions with the same MH+ ion have different 
fragmentation patterns, facilitating structural assignment. 
The isomeric compounds D, E, F and G all demonstrate MH+ ions at m/z 244 and compounds P 
and Q both have MH+ ions with m/z 258. Nonetheless, these alkylamides are distinguishable 
based on an MS–MS spectra. Table 2 illustrates the primary fragments that result from 
collisionally induced dissociation of several isomeric alkylamides. Structurally similar fragments 
have been grouped with designations of i, ii, iii, iv andv for ease of reference. 
One of the major groups of fragments formed by collisionally induced dissociation is the 
acyllium ion (fragment group i in Table 2), as previously reported by Hiserodt et al. [27]. These 
ions form due to a charge-remote hemolytic cleavage that yields a resonant distonic radical 
cation, which subsequently undergoes hydrogen rearrangement. Alkylamides F and G (Fig. 2D 
and E) show an acyllium ion at m/z 171, while alkylamides D and E ( Fig. 2A and B) result in the 
acyllium ion at m/z 157. 
Two additional fragments useful for elucidation of alkylamide structure are the group ii and 
group iiifragments (Table 2). The group ii fragments result from the loss of the amide portion 
alkylamide, and correspond to the remaining alkyl chain. The group iii fragments are observed at 
an m/z value 2 amu above the group ii fragments. Recent work utilizing deuterated alkylamides 
suggests that in the diene alkylamides, group iii fragments are formed when an unsaturated bond 
is lost and the remaining double bond shifts to the 3 position (in 2,4-dienes), with a subsequent 
gain of two hydrogens [27]. 
In combination, the group ii and iii ions can be used to determine (1) whether the alkylamide is a 
diene; (2) how many carbons are present in the alkyl chain; and (3) the identity of the amide 
moiety (isobutyl versus 2-methylbutyl). Isobutylamides will have two fragments corresponding 
to a loss of 101 (group ii) and 99 (groupiii) from the MH+ precursor ion (Fig. 2D–F). For 2-
methylbutylamides, the fragments will reflect the additional carbon in the amide moiety, and 
fragment ions corresponding to a loss of 115 (group ii) and 113 (group iii) from the 
MH+ precursor ion will be observed (Fig. 2A–C). 
The group iv fragments (Table 2) correspond to the MH+ ion of the protonated alkylamide that 
remains after loss of the N-alkyl group. Loss of the N-isobutyl group results in a significant 
fragment (relative intensity 26–60%) at m/z 188 for compounds F and G and 185 for compound 
Q, while loss of the N-(2-methylbutyl) group results in a fragment with m/z 174 for compounds 
D and E (relative intensity 56–100%) and a fragment withm/z 202 for compound P. The mass 
that is lost to form the group iv fragment serves as an additional confirmation to distinguish 
isobutylamides from 2-methylbutylamides. 
The final fragments that result from collisionally induced dissociation of alkylamides are 
group v in Table 2. They are formed by cleavage of various CC bonds on the N-alkyl substituent 
(Fig. 2). The group v fragments are useful for verifying whether the N-alkyl substituent is a 2-
methylbutylamide or isobutylamide. 
An example of the utility of MS–MS for structural elucidation of alkylamides can be 
demonstrated for the specific case of alkylamide P, trideca-2E,7Z-diene-8,10-diynoic acid 
isobutylamide. The MS–MS spectrum of the precursor ion at m/z 258 for this compound is 
shown in Fig. 2F. An acyllium ion (group i) is present atm/z 185. This suggests a thirteen carbon 
alkyl chain. This chain length is further confirmed by the group iifragment at m/z 157. The 
presence of the group iii fragment (m/z 159) indicates that the compound is indeed a diene 
alkylamide, and, the characteristic loss of 99 to form this fragment (258–159 = 99) suggests that 
the compound is an isobutylamide rather than a 2-methylbutylamide. The high intensity 
group iv fragment at m/z202 further confirms that the N-alkyl group is an isobutylamide. The 
low intensity group v fragments also confirm an N-isobutyl group rather than an N-2-
methylbutyl group; additional group v fragments would be observed for a 2-methylbutylamide. 
Thus, the identity of the compound is proposed to be trideca-2E,7Z-diene-8,10-diynoic acid 
isobutylamide, which has previously been shown to occur in E. pallida, but rarely is reported as 
occurring in E. purpurea [33]. The E/Z assignments for trideca-2E,7Z-diene-8,10-diynoic acid 
isobutylamide have been made based on comparison of the relative retention times observed in 
this study with those reported previously [33], and are only tentative without NMR confirmation. 
With HPLC–ESI-MS and MS–MS data such as those shown in Fig. 1 and Fig. 2, all of the 
previously identified alkylamides from E. purpurea in Table 1 except undeca-2E-ene-8,10-
diynoic acid isobutylamide (compound C) were identified in the extracts prepared in this study. 
Although past work cites the presence of undeca-2E-ene-8,10-diynoic acid isobutylamide in E. 
purpurea root [34] and [35], this compound was not detected in the echinacea extracts used for these 
studies. A commercially available standard of this compound was readily detectable with limit of 
detection of 0.15 μM, therefore, it can be concluded that undeca-2E-ene-8,10-diynoic acid 
isobutylamide was not present in the extracts at concentrations above 0.15 μM. Binns et al. [36], 
using solely UV spectra and retention time, previously identified undeca-2E-ene-8,10-diynoic 
acid isobutylamide compound in E. purpurea roots of wild plants but not cultivated germlings. 
Hence, it is possible that some genetic strains of E. purpurea contain undeca-2E-ene-8,10-
diynoic acid isobutylamide while others do not. However, our laboratory has investigated over 
20 different US sources ofE. purpurea (data not included) and thus far not detected this 
compound. Another possibility is that previous reports of the presence of undeca-2E-ene-8,10-
diynoic acid isobutylamide in E. purpurea were due to improperly identified plant material. 
Another Echinacea species, E. angustifolia, does produce significant levels of undeca-2E-ene-
8,10-diynoic acid isobutylamide, and the misidentification of echinacea species has often been 
documented [15], [37] and [38]. 
In addition to aiding in structural elucidation of known alkylamides, with HPLC–ESI-MS it was 
possible to tentatively identify a new alkylamide, the structure of which has not been previously 
published. This compound is undeca-2Z,4E-diene-8,10-diynoic acid 2-methylbutylamide 
(compound E in Table 1). Identification of this compound was based on retention time and the 
correlation between MS–MS fragmentation pattern and alkylamide structure. The mass and 
fragmentation pattern for compound E (Fig. 2) confirms that it is a 2-methylbutylamide, and 
indicates the level of saturation and length of the carbon chain. The mass spectral data do not 
indicate stereochemistry or bond position; however, relative retention time does suggest that this 
compound is the 2Z/4E isomer of compound D. For the previously identified alkylamide isomers 
that vary by the 2E/4Z and 2Z/4E stereochemistry, such as compounds A/B and F/G, we have 
demonstrated (Fig. 1) that the 2E/4Z isomer elutes before the 2Z/4E isomer. Thus, it is logical to 
assume a similar relationship in stereochemistry between compounds D and E. However, as 
noted earlier, without NMR confirmation, the reported stereochemistry of this new alkylamide is 
only tentative. 
Bauer and Remiger previously demonstrated that with reversed phase HPLC, alkylamides with 
terminal alkynes elute early in the separation followed by tetraene alkylamides [33]. For the 
purposes of this discussion, compounds A–G, J, P and Q are designated as polyacetylene amides, 
while the term “tetraenes” refers to isobutylamides with four double bonds in the alkyl chain. 
Consistent with the Bauer study, our results (Fig. 1) indicate that the polyacetylene amides (A, B, 
C, D/E, F/G, H, J, P, Q) elute early in the separation, between 25 and 31 min, followed by the 
tetraenes and dienes (K, L, M, N and O). These findings are significant in that alkynes, 
specifically 8,10 terminal alkynes, have been shown to modulate CYP 450 function [34], while 
tetraene isomer L and alkylamides N and O are ligands of the CB2 receptor [14]. The results 
in Fig. 1 suggest preparatory scale HPLC could be used to separate groups of alkylamides with 
differing physiological and pharmacological activity. 
3.2. Calibration results and method validation 
Table 3 illustrates the linear regression equations and statistical data for the alkylamide 
standards. The linear range of the calibration curves was from 1 to 500 μM for dodeca-2E-ene-
8,10-diynoic acid isobutylamide (J), and from 1 to 100 μM for dodeca-2E,4E,8Z,10Z-tetraenoic 
acid isobutylamide (L). Correlation coefficients (R2) of the alkylamide standards were 0.999 (J) 
and 0.993 (L). The limit of detection (concentration required to give a signal to noise ratio, S:N, 
of 3:1) for isobutylamides dodeca-2E-ene-8,10-diynoic acid and dodeca-2,4,8,10-tetraenoic acid 
were 0.051 and 0.99, respectively. Limits of quantitation (based on S:N of 10:1) were 1.7 and 
3.3, respectively. 
Table 3. Calibration parameters, limits of quantification (LOQ) and limits of detection (LOD) 
for E. purpurea alkylamides. 
 Slope 
(±SDa) 
Intercept 
(±SDa) 
R2 Linearity 
(μM) 
LOD 
(μM) 
LOQ 
(μM) 
Dodeca-2E-ene-8,10-diynoic 0.757 8.00 0.999 1.0–500 0.051 1.7 
acid isobutylamide (J) (±0.013) (±0.023) 
Dodeca-2E,4E,8Z,10Z-
tetraenoic acid isobutylamide 
(L) 
0.813 
(±0.040) 
6.95 
(±0.070) 
0.993 1.0–100 0.99 3.3 
a SD: Standard deviation. 
Table 4 shows the results of method validation for the quantitative analysis of alkylamide 
content, which was accomplished using International Committee of Harmonization (ICH) 
guidelines [28], as described in Section 2.7. The values for the residuals, repeatability, and 
intermediate precision conform to the parameters for method validation according to the ICH. 
Table 4. Validation parameters for quantitative analysis of E. purpurea alkylamides. 
Dodeca-2E-ene-8,10-diynoic acid isobutylamide (J) 
Theoretical 
concentration (μM)a 
Measured 
concentration (μM)b 
Residues 
(%)c 
Repeatability 
(%)d 
Intermediate 
precision (%)e 
1.0 1.1 14 3 2 
10 8.8 −12 2 2 
50 44 −11 1 3 
100 99.6 −0.3 1 4 
500 568 13 0.5 0.7 
 Dodeca-2E,4E,8Z,10Z-tetraenoic acid isobutylamide (L)f 
1.0 0.99 −.5 3 6 
10 9.7 −3 3 2 
50 49 −3 0.5 4 
100 105 5 3 0.6 
a Theoretical concentration based on the mass of standard per volume of solution. b Measured 
concentration for a given standard is the average of the back-calculated concentration (from the 
calibration curve) for three analyses conducted on three separate days. c The residuals (Res) are 
calculated by first determining the difference between the measured concentration (CM) and the 
theoretical concentration (CT) and then dividing this value by the measured concentration: 
Res = (CM − CT)/CM × 100. d Repeatability corresponds to the relative standard deviation of the 
back-calculated concentration for triplicate analyses of the same standard on the same day. e 
Intermediate precision corresponds to the relative standard deviation of the back-calculated 
concentration for triplicate analyses of the same standard on three different days. f Validation 
results are reported for dodeca-2E,4E,8Z,10Z-tetraenoic acid isobutylamide up to 100 μM, the 
upper limit of the linear range. 
3.3. Comparison of alkylamide yield in various E. purpurea extracts 
Three extracts were chosen for comparison of alkylamide content. One of these (fresh 1:2) was 
prepared from fresh E. purpurea roots using 1 g roots for every 2 mL of solvent. The other two 
were prepared from dryE. purpurea roots, one using 1 g dried roots per 11 mL solvent (1:11) and 
the other1 g dried roots per 5 mL solvent (1:5). All of the three extracts contain the same 
percentage of ethanol (69%). The extracts differ only in the nature of starting material (fresh or 
dry root) and the ratio of root:solvent. Once the mass of the fresh roots is adjusted to account for 
water content, the fresh 1:2 and dry 1:11 extract have equivalent ratios of dry weight plant 
material:mL solvent. Therefore, by comparing the composition of the fresh 1:2 and dry 1:11 
extracts, it should be possible to determine how extract composition differs depending on 
whether fresh or dried roots are used for extraction. The two extracts prepared from dried E. 
purpurea differ only in the ratio of g root:mL solvent (1:11 versus 1:5), therefore, by comparing 
the composition of the dry 1:11 and dry 1:5 extracts, it should be possible to determine whether 
changing the root:solvent ratio has an effect on extract composition. 
Utilizing available alkylamide standards, the quantities of alkylamides in the fresh and dry E. 
purpurea root extracts were determined. Table 5 displays these results in terms of concentrations 
of the isomeric tetraenes (compounds K, L and M) and dodeca-2E-ene-8,10-diynoic acid 
isobutylamide (compound J) per millilitre of solvent. The three different Echinacea extracts, 
fresh 1:2, dry 1:11 and dry 1:5, all contained these alkylamides. However, as shown in Table 5, 
the dry 1:5 extract contained the greatest amount of these compounds. This is to be expected 
given the lower ratio of g roots:mL solvent used in the preparation of the 1:5 extract. 
Table 5. Quantities of the isomeric alkylamides K, L and M and alkylamide J in ethanolic 
extracts of E. purpurea root. 
Type of extract Alkylamides K, L and M Alkylamide J 
 Fresh 1:2 Dry 1:11 Dry 1:5 Fresh 1:2 Dry 1:11 Dry 1:5 
Mean concentration (mg/mL)a 1.4 1.6 7.2 0.0047 .0072 0.013 
Mean concentration (mM)a 5.7 6.4 29 0.019 0.029 0.054 
SEb 0.5 0.2 3 0.001 0.0004 0.002 
a The mean concentration was calculated for four replicate extractions (n = 4). b SE represents the 
standard error of the concentrations in mM. 
In order to easily compare how efficiently alkylamides were extracted in the three different E. 
purpureaextracts, the quantity of each alkylamide (mg) was divided by the dry weight of E. 
purpurea root (g) used to prepare an equivalent volume of extract. The resulting value is referred 
to as “alkylamide yield” ( Fig. 3). The only difference in the fresh 1:2 versus the dry 1:11 
extracts is whether fresh or dry root was used in their preparation. Therefore, assuming no loss of 
alkylamide during the drying process, alkylamide yield would be expected to be very similar for 
these two extracts. Indeed, the alkylamide yield for the fresh 1:2 versus the 1:11 were 
comparable for the tetraenes K, L, M ( Fig. 3A), 15.3 ± 2.5 versus 17.1 ± 1.3 mg/g, respectively. 
For alkylamide J, the yield was lower in the 1:2 extract as compared to the 1:11 extract 
(0.0506 ± 00.0053 versus 0.0775 ± 0.0024 mg/g, respectively). This difference could be due to 
differences in particle size between the extracts, which may have given rise to more efficient 
extraction in the dry as compared to the fresh extract. Importantly, comparison of alkylamide 
yield for the 1:2 and 1:11 extracts does not indicate any significant degradation of alkylamides 
due to drying. The extracts in this study were prepared from roots immediately after completion 
of oven drying. Kabganian et al. [39] came to the same conclusion finding no degradation of 
alkylamides in roots that were oven dried. Whether or not there is a loss in alkylamide content 
in E. purpurea roots stored for long periods of time would be a worthy subject of a future 
investigation. 
 
Fig. 3. Comparison of alkylamide yield in fresh 1:2, dry 1:11 and dry 1:5 E. purpurea root 
ethanolic extracts. All concentrations represent the mean from four replicate extractions at room 
temperature. Error bars denote standard error of the mean (SEM). Comparisons were made 
between fresh 1:2, dry 1:11 and 1:5 extracts, with (*) indicating p < 0.005; (**) 
indicating p < 0.001. Alkylamide yield is similar in the fresh 1:2 and dry 1:11 extracts, indicating 
no loss of alkylamides in the drying process. Better yield of alkylamide J was obtained for the 
fresh 1:2 versus dry 1:11 extract. 
In comparing the extraction yield of the alkylamides between the 1:11 versus 1:5 dry root 
extracts, a logical prediction, provided a 1:5 extract is not saturated, would be that the alkylamide 
yield would be the same in the two extracts. As can be seen in Fig. 3, however, this is not the 
case. While alkylamide yield is similar in the two extracts, there are statistically significant 
differences. For alkylamides K, L, M (Fig. 3A), extraction is more efficient in the 1:5 as 
compared to the 1:11 extract. This is the opposite of what would be expected if the solution were 
saturated in the case of the 1:5 extract; therefore, saturation is not the cause of the differences. 
Conversely, for alkylamide J, extraction is more efficient in the 1:11 extract than the 1:5 extract 
(Fig. 3B). Previous studies have established that solvent interactions of N-alkylamides differ 
depending on molecular structure and the surrounding phytochemical matrix [40]. Therefore, it is 
plausible that extraction of certain alkylamides is favored in more dilute extracts, while 
concentrated extracts favor the extraction of structurally different species. 
3.4. Comparison of yield of dissolved solids in various E. purpurea extracts 
The amount of total dissolved solids in the three extracts described in Section 3.3 was compared. 
Total dissolved solids are a measure of how much material overall (alkylamides as well as other 
compounds) was dissolved in the original extract. When the mass of dissolved solids is divided 
by the dry weight of the plant material used to produce an equivalent volume of extract, the 
resulting value is referred to as “extract yield,” which is a measure of how much of the initial 
starting material was converted into extract. 
Fig. 4 displays the extract yield (mg dissolved solids/g dry root) for the three E. 
purpurea extracts under investigation. Overall, the extract yield was similar for all three extracts. 
However, the yield for the fresh root extract (196.6 ± 2.7 mg/g) was slightly lower than the two 
dry root extracts (269 ± 12 and 290 ± 24 mg/g for the 1:11 and 1:5 extracts, 
respectively, p < 0.001). As mentioned previously, a similar effect was observed for alkylamide 
J. This difference could possibly be attributed to differences in particle size in fresh versus dry 
extractions. Between the two dried extracts, there was no statistically significant difference in 
extract yield. This similarity between 1:11 and 1:5 extracts indicates that it is possible, by 
doubling the quantity of root used for the extraction, to double the amount of material dissolved 
in the solvent, at least up to a ratio of 1:5. It should be pointed out that because of the greater 
amount of root used to prepare the 1:5 extract, this extract does, overall, contain a greater 
concentration of dissolved solids then the 1:11 extract. However, there is no significant 
difference between the two extracts when the amount of dissolved solids is expressed relative to 
the mass of root used in the extract. 
 
Fig. 4. Yield of dissolved solids in ethanolic extracts of Echinacea purpurea roots. Mass of 
dissolved solids was determined by evaporation of the ethanol/water solvent from aliquots of 
extracts, and this value was ratioed to the quantity of root (dry weight) used to prepare an 
equivalent volume of extract to calculate dissolved solids yield. Yield of dissolved solids in the 
1:11 extraction does not statistically differ from 1:5 extraction. The fresh root extraction (1:2) 
differs from the 1:11 and the 1:5 extraction by 26.8% and 32.4% respectively. (*) 
indicates p < 0.005;(**) indicates p < 0.001. 
3.5. Extraction of the tetraene isomers as a function of maceration time 
Lastly, the quantity of the isomeric dodeca-2,4,8,10-tetraenoic acid isobutylamides present in a 
maceratingE. purpurea extract against time was measured ( Fig. 5). The results are all displayed 
relative to that achieved on the first day when concentration was measured (day 2). These 
tetraene isobutylamides are significant because they typically compose from 30 to 70% of the 
total alkylamides in echinacea products[41]. The results in Fig. 5 demonstrate that the extraction 
of dodeca-2,4,8,10-tetraenoic acid isobutylamides is complete by day 2. Thus, in terms of the 
extraction of specifically these compounds, maceration beyond day 2 should not be necessary. 
This finding is particularly interesting given that many dietary supplements manufacturers 
currently suggest that the appropriate time for a maceration is 2 weeks or longer, depending on 
the part of the plant used [25]. While commonly used long maceration times seem to have little 
effect on alkylamide content, long maceration times could actually be detrimental if some 
compounds (for example caffeic acid derivatives) degrade during maceration. Future 
investigations of the optimal maceration time for producing an extract with maximal 
concentrations of all desirable constituents are warranted. 
 
Fig. 5. Relative concentration of dodecatetraenoic acid isobutylamides (alkylamides K, L and M) 
in an E. purpurea root extraction over time. Relative concentrations (CR) were calculated by 
dividing the concentration of each sample (CS) by the concentration at day 2 (Cday2) and 
converting to percent: CR = CS/Cday2 × 100. Samples were taken daily over 28 days from dry root 
(1:11) ethanolic maceration of E. purpurea. Results show that maximal extraction of 
dodecatetraenoic acid isobutylamide is achieved by day 2. 
4. Conclusion 
With these investigations, it has been demonstrated that HPLC–ESI-MS is an excellent technique 
for comprehensive analysis of the alkylamide content of E. purpurea extracts. Using HPLC–ESI-
MS, a more comprehensive alkylamide profile was obtained than is typically possible with other 
analytical approaches. By relying on collisionally induced dissociation, it was possible to 
distinguish between isomeric alkylamides, and to tentatively identify a new E. 
purpurea alkylamide, undeca-2Z,4E-diene-8,10-diynoic acid 2-methylbutylamide. In addition, 
the validated method facilitated quantitative comparison of alkylamide content among extracts 
prepared with different extraction procedures. All three extraction techniques investigated here 
(fresh 1:2, dry 1:5 and dry 1:11) resulted in very similar alkylamide profile, and gave similar 
yields of alkylamides and of total dissolved solids. The similarity in alkylamide content in fresh 
1:2 and dry 1:11 extracts indicates that drying of root material at 50 °C does not result in a loss 
of alkylamides. It appears that either fresh or dried roots can be used to prepare extracts with 
high alkylamide content, although the overall yield was slightly lower for fresh extracts. Lastly, 
the analysis of a 1:2 fresh root ethanolic extract suggest that the maximum concentration of the 
tetraenes (dodecatetraenoic acid isobutylamides) is achieved by day 2 in an ethanolic extraction. 
Although alkylamide yields were, overall, similar with the three extraction techniques, there 
were some statistically significant differences in quantities of alkylamides extracted. Notably the 
isomeric tetraenes were extracted more efficiently with a root to solvent ratio of 1:5 (w:v) as 
compared to a ratio of 1:11, while dodeca-2E-ene-8,10-diynoic acid isobutylamide was extracted 
more efficiently with a ratio of 1:11. Given that the biological activity of alkylamides differs 
depending on structure, these suggest that pharmacological activity of E. purpurea extracts could 
differ depending on the ratio of root:solvent used in extraction. Ultimately, in vitro and in vivo 
studies are needed to elucidate the differences in pharmacokinetic and pharmacodynamic activity 
of extracts of various Echinacea spp. The results presented in this paper do, however, suggest 
that it would be erroneous to assume that all ethanolic extracts of E. purpurea result in 
equivalent phytochemical profiles. 
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